transdermal ozone linked to 50%+ symptom reduction in 91% of ischemic heart cases
Ozonetherapy produced valid improvement (≥50% symptom reduction) in 91% of 142 patients with ischemic heart disease across all functional classes.
What this means for you
When the cardiovascular system is under stress, circulation and oxygen delivery to the heart muscle can suffer. This finding suggests ozone exposure may support meaningful improvements in how the body manages that load — with over 9 in 10 cases showing at least half their symptoms ease. For wellness-focused individuals, that points to ozone's potential role in circulatory resilience.
The published research
Ozonetherapy in the Treatment of Internal Diseases
This page describes a documented finding about the underlying wellness technology. It is not a marketing claim about any specific device. For information about HOCATT specifically, visit hocatt.com.